non-gaap diluted earnings per share for the quarter were $num-one, an increase of num-two% over the prior year quarter.
our gaap diluted earnings per share for the quarter were $num-one.
group revenue for the june quarter was $num-one million, an increase of num-two% over the prior-year quarter.
taking a closer look at our geographic distribution and excluding revenue from our software-as-a-service business, our sales in us, canada and latin america countries were $num-one million, an increase of num-two% over the prior-year quarter.
sales in europe, asia and other markets totaled num-one million, an increase of num-two% over the prior-year quarter and an increase of num-three% in constant currency terms.
by product segment, us, canada and latin america device sales were $num-one million, an increase of num-two% over the prior-year quarter.
masks and other sales in europe, asia and other markets were num-one million, a decrease of num-two% over the prior-year quarter, while in constant currency terms, a num-three% decrease.
in constant currency terms, revenue increased by num-one% compared to the prior-year quarter.
today, our board of directors declared a quarterly dividend of $num-one per share, reflecting the board's confidence in our strong liquidity position and operating performance.
non-gaap net income for the quarter was $num-one million, an increase of num-two% over the prior year quarter.
in europe, asia and other markets, device sales totaled $num-one million, an increase of num-two% over the prior-year quarter or in constant currency terms, a num-three% increase.
we estimate that the incremental net revenue benefit from covid related impacts was in the order of num-one million, reflecting estimated incremental ventilator and related accessory revenue of num-two million, partially offset by an estimated num-three million impact on our sleep revenue relative to our pre-covid forecasts.
masks and other sales were num-one million, an increase of num-two% over the prior-year quarter.
we had year on year annual num-one% top line revenue growth to $num-two billion in annual revenue for resmed.
during the quarter, our software-as-a-service business grew num-one% compared to the year ago period.
software-as-a-service revenue for the fourth quarter was num-one million, an increase of num-two% over the prior-year quarter.